Mass Dismissals From Federal Science Boards Risk Long-Term Disruption to US Rulemaking

The removals target advisory bodies that assist agencies such as the Environmental Protection Agency (EPA), the Food and Drug Administration (FDA), the Department of Energy, and the Department of the Interior. These panels, which operate largely out of public view, serve as a critical bridge between independent empirical research and federal policy implementation. Researchers and administrative policy experts warn that the sudden reduction in technical oversight could produce multi-year delays in regulatory evaluations, increase legal vulnerabilities for federal rules, and erode public confidence in executive decision-making.

What happened

The systematic dismissal of scientific advisory board members has unfolded across executive branch departments that rely on external expertise to interpret complex data, according to reporting by Katia Riddle. Federal agencies routinely establish advisory committees to consult on highly specialized questions that internal staff may lack the capacity or specific technical expertise to resolve independently. These board members undergo background ethics checks, sign government non-disclosure agreements, and dedicate hundreds of unpaid hours annually to reviewing peer-reviewed literature, draft regulations, and risk assessments.

Over the course of the administration's current term, agency leadership has issued termination notices to scientists serving on these panels, effectively halting the operations of numerous specialized committees. In some instances, entire boards have been dissolved or left without a quorum, while in others, individual researchers have been removed prior to the conclusion of their appointed terms.

The impacted committees include bodies responsible for evaluating environmental pollutants, assessing food safety protocols, advising on nuclear waste management, and evaluating grant applications for federal research initiatives. By removing these experts, executive agencies have suspended ongoing scientific peer reviews that are mandatory steps in the federal regulatory pipeline.

While agency heads possess statutory authority over board appointments under administrative law, the abrupt scale of the removals has disrupted active working groups. Draft scientific synthesis reports, which often take years to compile, have been shelved or left incomplete, leaving agencies without the technical documentation typically required before formally proposing new standards or revising existing guidelines.

The reduction of external scientific advisory boards carries direct consequences for public policy, industrial compliance, public health, and administrative law. Under the Administrative Procedure Act (APA) of 1946, federal agencies are required to demonstrate that public rules are grounded in evidence and are not arbitrary or capricious. When agencies issue regulations on complex issues—such as exposure thresholds for industrial chemicals, emissions limits for power plants, or clinical trial guidelines for novel therapeutics—courts closely examine whether the executive body evaluated the best available science.

Without the formal stamp of independent peer review provided by FACA committees, agency rules become significantly more vulnerable to legal challenges in federal court. Industry groups, environmental organizations, and state attorneys general frequently sue executive agencies over administrative decisions. If a judge finds that an agency bypassed statutory scientific consultation or based a rule on incomplete technical reviews, the court can vacate the rule entirely, creating years of regulatory uncertainty for commercial sector investments.

Furthermore, the loss of experienced academic and technical advisors slows down federal approvals and standard-setting. Commercial entities rely on predictable regulatory timelines to bring new drugs, chemical products, energy infrastructure, and agricultural technologies to market. If advisory panels are inactive, administrative backlogs grow, delaying decisions that affect broader economic competitiveness.

From a public health perspective, scientific advisory boards provide an early-warning mechanism for emerging threats, such as novel biological contaminants, microplastic risks, or industrial chemical toxicity. Dismantled panels reduce the federal government's capacity to synthesize rapid scientific consensus during public health or environmental crises.

The background

The formal framework for government consultation with external experts was codified in the Federal Advisory Committee Act (FACA) of 1972. Enacted by Congress to ensure transparency, accountability, and objectivity in executive branch decision-making, FACA established strict operational parameters for the hundreds of advisory committees operating across the federal government. The law requires that panel memberships remain fairly balanced in terms of points of view, that meetings be open to the public, and that committee records be preserved for public inspection.

Over the past half-century, these boards have played a pivotal role in major policy milestones, including the setting of National Ambient Air Quality Standards under the Clean Air Act, the approval of life-saving medical devices at the FDA, and the management of public lands under the Department of the Interior. Major panels like the EPA’s Science Advisory Board (SAB) and the Clean Air Scientific Advisory Committee (CASAC) are explicitly mandated by federal statutes to provide independent technical reviews.

However, executive authority over advisory panels has long been a flashpoint between political leadership and the scientific community. During President Trump’s first term (2017–2021), the administration pursued similar restructuring efforts. In June 2019, President Trump signed Executive Order 13875, which directed federal departments to cut the total number of executive advisory committees by one-third. Concurrently, agency leaders implemented new eligibility rules; for example, the EPA under Administrator Scott Pruitt prohibited scientists receiving EPA research grants from serving on advisory panels, a policy that significantly altered the composition of academic representation before being invalidated by federal courts in 2020.

When President Joe Biden took office in 2021, his administration reversed those policies, directing agencies to reset major advisory boards, re-hire dismissed scientists, and strengthen scientific integrity guidelines across departments. The current dismissals reported by Katia Riddle represent a continuation of this decade-long tug-of-war between presidential administrations seeking policy alignment and traditional scientific institutions prioritizing peer-reviewed expertise.

Reaction

The dismissals have drawn intense criticism from professional scientific organizations, public interest advocates, and academic leaders. Organizations such as the American Association for the Advancement of Science (AAAS) and the Union of Concerned Scientists have previously voiced concern over presidential efforts to alter scientific advisory structures, arguing that politically motivated dismissals compromise the integrity of public health and safety standards.

Academic institutions, whose faculty members constitute a substantial portion of FACA panels, have expressed concern that the removals undermine the tradition of civic scientific service. Researchers invest considerable institutional time into federal panel reviews, treating the uncompensated role as a vital professional duty.

Conversely, supporters of executive administrative reform argue that cabinet secretaries must retain full authority to align advisory bodies with the priorities of the elected president. Conservative policy experts and industrial groups have occasionally criticized traditional scientific advisory panels for acting as bureaucratic bottlenecks or advancing regulatory agendas that exceed economic feasibility. In congressional forums, conservative lawmakers have historically supported efforts to increase industry representation on technical boards to balance academic perspectives.

Congressional oversight committees are expected to scrutinize the dismissals. Lawmakers on relevant Senate and House panels—including the House Committee on Science, Space, and Technology—possess jurisdiction to hold inquiries into whether agencies are complying with statutory consultation mandates established by Congress.

What we don't know yet

Several key aspects of the panel purges remain unclear. The total aggregate number of dismissed advisors across all cabinet-level departments has not been formally published by the White House or the General Services Administration (GSA), which tracks federal advisory committee data annually.

It is also unknown whether agencies intend to leave these advisory seats permanently vacant, dissolve specific committees entirely, or populate the boards with new nominees who align more closely with the administration's deregulatory policies. If the administration opts to nominate new members, the timeline for ethics vetting and public notice requirements under FACA could take months to complete.

Additionally, it remains to be seen whether dismissed scientists or advocacy organizations will initiate legal action against executive agencies. Lawsuits could challenge the removals on the grounds that agencies are violating statutory directives requiring specific advisory board operations, or that altered panels fail to meet FACA’s legal mandate for fair representation.

What to watch

This report is based on original reporting published by journalist Katia Riddle on August 29, 2026.